Page last updated: 2024-08-23

ioxitalamic acid and fluorodeoxyglucose f18

ioxitalamic acid has been researched along with fluorodeoxyglucose f18 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andersen, F; Berthelsen, AK; Holm, S; Højgaard, L; Klausen, TL; Loft, A	1

Trials

1 trial(s) available for ioxitalamic acid and fluorodeoxyglucose f18

Article	Year
PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients. European journal of nuclear medicine and molecular imaging, 2005, Volume: 32, Issue:10 Topics: Adult; Aged; Artifacts; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Injections, Intravenous; Iothalamic Acid; Male; Middle Aged; Neoplasms; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Single-Blind Method; Subtraction Technique; Tomography, X-Ray Computed	2005

Article

Year

PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients.

European journal of nuclear medicine and molecular imaging, 2005, Volume: 32, Issue:10

Topics: Adult; Aged; Artifacts; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Injections, Intravenous; Iothalamic Acid; Male; Middle Aged; Neoplasms; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Single-Blind Method; Subtraction Technique; Tomography, X-Ray Computed

2005